ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
2,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
4,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,Y
8,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
8,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
9,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
12,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
13,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
14,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
17,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
18,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
19,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
21,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
22,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
22,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
23,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
24,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
24,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
25,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
28,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
29,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
30,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
31,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
32,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
32,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
33,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
33,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
34,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
35,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
36,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
37,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
38,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
39,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
40,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
42,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
43,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
44,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
45,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
46,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
46,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
49,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
50,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
51,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
52,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
53,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
54,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
54,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
55,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
56,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
57,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
57,3,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
58,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
59,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
59,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
60,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
60,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
60,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
60,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
60,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
61,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
61,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
61,4,Migraine,Migraine headaches,Headaches,Nerv,N
61,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,6,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
61,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,8,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
61,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,1,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
62,2,Teratogenicity,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
63,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
63,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
63,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
64,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
64,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
64,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
65,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
65,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
65,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
66,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
66,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
66,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
67,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
67,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
67,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
68,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
68,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
68,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
69,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
69,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
69,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
70,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
70,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
70,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
71,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
71,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
71,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
72,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
72,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
72,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
73,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
73,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
73,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
74,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
74,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
74,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
75,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
75,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
75,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
76,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
76,2,Nasal vestibulitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
76,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
77,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
77,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
77,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
77,5,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
77,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,8,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
77,9,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
77,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
77,11,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
77,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
77,13,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
77,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
77,15,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
77,16,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
77,17,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,18,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,19,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
77,20,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,21,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
78,1,Application site pustules,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
78,2,Application site pustules,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
78,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
78,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
78,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
78,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
78,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
78,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
78,9,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
78,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
81,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
82,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
82,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
82,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
83,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
84,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
85,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
85,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
85,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,1,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
86,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
86,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
87,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
87,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
87,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
87,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
87,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
87,6,Duodenogastric reflux,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
87,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
87,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
87,9,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
87,10,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
87,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,12,Migraine,Migraine headaches,Headaches,Nerv,N
87,13,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
87,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
87,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
88,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
88,2,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
88,3,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
88,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
88,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
88,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
89,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
89,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
89,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
90,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
90,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
90,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
91,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
92,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
93,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
95,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
96,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
96,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
97,1,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
98,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
100,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
101,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
101,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
101,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
101,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
101,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
102,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
103,1,Rhinitis allergic,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
104,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
105,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
105,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
105,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
106,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
106,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
106,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
106,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
106,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
107,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
108,2,Ectropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
108,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
108,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
108,5,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
108,6,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
109,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
110,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
110,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
110,3,Headache,Headaches NEC,Headaches,Nerv,N
110,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,1,Headache,Headaches NEC,Headaches,Nerv,N
112,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
112,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
113,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
113,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
113,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
113,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
113,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
114,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
114,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
116,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
116,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
117,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
118,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
119,1,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
119,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
119,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
